← Back to all trials
Not Yet Recruiting
NCT07882420
Role of Artificial Intelligence in Breast Cancer Screening Via Mammography
Conditions: Breast Cancer
Sex: Female
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 1222
Sponsor: Centre Antoine Lacassagne
Location: Institut Paoli Calmette Marseille
Summary
to evaluate the diagnostic performance of radiologists using the Transpara™ Incepto® software to interpret 2D mammograms with tomosynthesis as part of breast cancer screening
Eligibility Criteria
Inclusion Criteria:
* A woman referred for a bilateral mammogram as part of individual or organised screening,
* Patient aged 18 or over,
* A patient who has read the information leaflet and signed the informed consent form,
* A patient with health insurance cover.
Exclusion Criteria:
* Patients with a history of breast cancer,
* Patients with a history of breast surgery (cosmetic and/or therapeutic),
* Patients with a history of radiotherapy to the breast,
* Vulnerable populations and participants as defined in Articles 64 to 68 of Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017.
Source: ClinicalTrials.gov (NCT07882420). StuddyBuddy aggregates publicly available trial information.